Correlation Between Novo Nordisk and FORTRESS BIOTECHPRFA

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and FORTRESS BIOTECHPRFA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and FORTRESS BIOTECHPRFA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and FORTRESS BIOTECHPRFA 25, you can compare the effects of market volatilities on Novo Nordisk and FORTRESS BIOTECHPRFA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of FORTRESS BIOTECHPRFA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and FORTRESS BIOTECHPRFA.

Diversification Opportunities for Novo Nordisk and FORTRESS BIOTECHPRFA

0.61

Correlation Coefficient

Novo Nordisk  FORTRESS BIOTECHPRFA

Poor diversification

The 3 months correlation between Novo and FORTRESS is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and FORTRESS BIOTECHPRFA 25 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FORTRESS BIOTECHPRFA and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with FORTRESS BIOTECHPRFA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FORTRESS BIOTECHPRFA has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and FORTRESS BIOTECHPRFA go up and down completely randomly.

Pair Corralation between Novo Nordisk and FORTRESS BIOTECHPRFA

Assuming the 90 days trading horizon Novo Nordisk AS is expected to under-perform the FORTRESS BIOTECHPRFA. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 1.58 times less risky than FORTRESS BIOTECHPRFA. The stock trades about -0.19 of its potential returns per unit of risk. The FORTRESS BIOTECHPRFA 25 is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  635.00  in FORTRESS BIOTECHPRFA 25 on January 30, 2025 and sell it today you would lose (65.00) from holding FORTRESS BIOTECHPRFA 25 or give up 10.24% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Novo Nordisk AS  vs.  FORTRESS BIOTECHPRFA 25

Novo Nordisk AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in May 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

FORTRESS BIOTECHPRFA

Risk-Adjusted Performance

Very Weak

Over the last 90 days FORTRESS BIOTECHPRFA 25 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, FORTRESS BIOTECHPRFA is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Novo Nordisk and FORTRESS BIOTECHPRFA

The main advantage of trading using opposite Novo Nordisk and FORTRESS BIOTECHPRFA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, FORTRESS BIOTECHPRFA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FORTRESS BIOTECHPRFA will offset losses from the drop in FORTRESS BIOTECHPRFA's long position.

The idea behind Novo Nordisk AS and FORTRESS BIOTECHPRFA 25 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.